[Influence of gestonoron-capronate (GC) upon uptake and metabolism of H3-testosteron in benign prostatic hypertrophy (BPH): in vivo-experiments (author's transl)].
D000005:Abdomen; D000368:Aged; D003692:Delayed-Action Preparations; D005866:Gestonorone Caproate / Q000494:pharmacology*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000378:metabolism; D011467:Prostate / Q000378:metabolism; D011470:Prostatic Hyperplasia / Q000378:metabolism*; D011955:Receptors, Drug; D013739:Testosterone / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000097:blood / Q000378:metabolism*; D014316:Tritium
D003692:Delayed-Action Preparations; D011955:Receptors, Drug; D014316:Tritium; D013739:Testosterone; D005866:Gestonorone Caproate
Einfluss von Gestonoron-Capronat (Depostat) auf Aufnahme und Stoffwechsel von H3-Testosteron im menschlichen Prostataadenom: In vivo-Untersuchungen